A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application...
In a decisive move to counter critical domestic medicine shortages caused by global macroeconomic headwinds, the Department of Pharmaceuticals (DoP) has granted an in-principle...